These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3544188)

  • 1. Treatment of reflux oesophagitis with a carbenoxolone/antacid/alginate preparation. A double-blind controlled trial.
    Young GP; Nagy GS; Myren J; Kronborg IJ; Logan KR; Reed PI; Hopper JL
    Scand J Gastroenterol; 1986 Nov; 21(9):1098-104. PubMed ID: 3544188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trial of a carbenoxolone/alginate antacid combination in reflux oesophagitis.
    Reed PI; Davies WA
    Curr Med Res Opin; 1978; 5(8):637-44. PubMed ID: 361348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
    Reed PI; Davies WA
    Am J Dig Dis; 1978 Feb; 23(2):161-5. PubMed ID: 341689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of pyrogastrone and cimetidine in the treatment of reflux oesophagitis.
    Maxton DG; Heald J; Whorwell PJ; Haboubi NY
    Gut; 1990 Mar; 31(3):351-4. PubMed ID: 2157637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period.
    Markham C; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():73-82. PubMed ID: 6259715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrogastrone for oesophagitis.
    Drug Ther Bull; 1979 Aug; 17(16):63-4. PubMed ID: 228924
    [No Abstract]   [Full Text] [Related]  

  • 7. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis.
    Scobie BA
    Med J Aust; 1976 Apr; 1(17):627-8. PubMed ID: 778564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid.
    Oderda G; Dell'Olio D; Forni M; Farina L; Tavassoli K; Ansaldi N
    Ital J Gastroenterol; 1990 Dec; 22(6):346-9. PubMed ID: 2131953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of gastroesophageal reflux with an original preparation containing alginate/antacid or pectinate/antacid].
    Stanciu C; Bălan G; Cijevschi C; Sănduiescu E; Frasin M; Filimon L; Ariton S; Busuioc I; Taraşi G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):233-6. PubMed ID: 4089324
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
    Smart HL; Atkinson M
    J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease.
    Chatfield S
    Curr Med Res Opin; 1999; 15(3):152-9. PubMed ID: 10621921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duodenal ulcer treated by carbenoxolone sodium. Endoscopically controlled trial (author's transl)].
    Carrilho FJ; Onishi I; Soares EC; Zeitune JM; Pareja JC; Amorim Filho J
    Arq Gastroenterol; 1978; 15(4):167-74. PubMed ID: 749854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone.
    Campisi D; Cataldo MG; Paterna S; Bivona A; Barbarino C
    Pharmatherapeutica; 1985; 4(3 Spec No):166-70. PubMed ID: 3903785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
    Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.